ClinicalTrials.Veeva

Menu

Prospective Randomized Trial On Episiorrhaphy (VICRYL)

A

ASST Fatebenefratelli Sacco

Status

Active, not recruiting

Conditions

Suture Materials

Treatments

Device: Antibacterial Vicryl Plus 2/0
Device: Standard Vicryl 2/0

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

An episiotomy refers to the incision of the perineum performed to increase the space of the vaginal opening to facilitate the birth of the newborn. Subsequently, the incision is closed by aligning the tissues without cutaneous and vascular alterations. Although a systematic review and metanalysis demonstrated that sutures coated with triclosan, a purified antimicrobial, prevent surgical site infections, there is no evidence in the literature regarding the use of antibacterial sutures for perineal plane compared to standard ones.

Therefore, the goal of this clinical trial is to compare the outcomes of incisions performed with standard Vicryl 2/0 sutures and antibacterial Vicryl Plus 2/0 sutures.

The study involves women giving birth at the Vittore Buzzi Children's Hospital, for whom an incision is necessary at the time of delivery. Participants will be evaluated at 48 hours (at the time of the hospital discharge visit), 40 days (at the postpartum visit), and 6 months (by phone interview) after delivery.

In particular, the aim of this study is to assess whether:

  • antibacterial Vicryl Plus 2/0 sutures reduce pain after delivery;
  • antibacterial Vicryl Plus 2/0 sutures improve the overall wound healing rate, avoid sexual, urinary or bowel disorders and the need for additional pharmacological, surgical, or physiotherapeutic interventions (in case of suboptimal wound healing).

This study also aims to validate a new ASEPSIS ( Additional Treatment, Serous exudate, Erythema, Purulent exudate, Separation of deep tissues, Isolation of bacteria and Stay) score for the evaluation of healing outcomes of episiotomies.

This is a double-blind, parallel-group randomized controlled trial. After obtaining informed consent, participants are randomly assigned either to the experimental group or the control group. Participants do not know the group they belong to, as the researchers; only the healthcare professional performing the suture knows it.

Enrollment

100 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pregnant women at term (more than 37 weeks);
  • age between 18 and 40 years;
  • women who give consent to participate in the study;
  • women who give birth during the recruitment period;
  • women for whom an episiotomy is necessary at the time of delivery.

Exclusion criteria

  • age lower than 18 years and more than 40 years;
  • gestational age lower than 37 weeks;
  • diabetes mellitus or gestational diabetes;
  • African and South-East Asian ethnicities;
  • cigarette smoking;
  • BMI higher than 30;
  • anemia;
  • lack of consent to participate;
  • complicated episiotomy and/or presence of other spontaneous perineal lacerations;
  • women lost to follow-up or who have undergone non-gynecological perineal interventions during the follow-up period.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups

antibacterial sutures
Experimental group
Description:
antibacterial Vicryl Plus 2/0 sutures.
Treatment:
Device: Antibacterial Vicryl Plus 2/0
non-antibacterial sutures
Active Comparator group
Description:
standard (non-antibacterial) Vicryl 2/0 sutures.
Treatment:
Device: Standard Vicryl 2/0

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems